nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—PLA2G4A—Epirubicin—sarcoma	0.549	1	CbGbCtD
Suramin—P2RY2—pericardium—sarcoma	0.0319	0.122	CbGeAlD
Suramin—F2—posterior vena cava—sarcoma	0.0202	0.0772	CbGeAlD
Suramin—RYR1—larynx—sarcoma	0.0133	0.051	CbGeAlD
Suramin—F2—knee—sarcoma	0.0121	0.0462	CbGeAlD
Suramin—F2—leg—sarcoma	0.00662	0.0254	CbGeAlD
Suramin—F2—forelimb—sarcoma	0.00657	0.0252	CbGeAlD
Suramin—F2—hindlimb—sarcoma	0.00591	0.0226	CbGeAlD
Suramin—SIRT1—endothelium—sarcoma	0.00579	0.0222	CbGeAlD
Suramin—SIRT5—mammary gland—sarcoma	0.00564	0.0216	CbGeAlD
Suramin—P2RY2—hematopoietic system—sarcoma	0.00556	0.0213	CbGeAlD
Suramin—F2—appendage—sarcoma	0.00507	0.0194	CbGeAlD
Suramin—FSHR—connective tissue—sarcoma	0.00503	0.0193	CbGeAlD
Suramin—SIRT1—mammary gland—sarcoma	0.00467	0.0179	CbGeAlD
Suramin—ARSA—mammary gland—sarcoma	0.00461	0.0177	CbGeAlD
Suramin—P2RX4—myometrium—sarcoma	0.00378	0.0145	CbGeAlD
Suramin—P2RX4—seminal vesicle—sarcoma	0.00342	0.0131	CbGeAlD
Suramin—SIRT1—myometrium—sarcoma	0.00331	0.0127	CbGeAlD
Suramin—P2RX4—hematopoietic system—sarcoma	0.00325	0.0124	CbGeAlD
Suramin—F2—endothelium—sarcoma	0.00306	0.0117	CbGeAlD
Suramin—RYR1—myometrium—sarcoma	0.00306	0.0117	CbGeAlD
Suramin—SIRT1—seminal vesicle—sarcoma	0.00299	0.0115	CbGeAlD
Suramin—ARSA—seminal vesicle—sarcoma	0.00296	0.0113	CbGeAlD
Suramin—FSHR—testis—sarcoma	0.00286	0.011	CbGeAlD
Suramin—SIRT1—hematopoietic system—sarcoma	0.00285	0.0109	CbGeAlD
Suramin—ARSA—hematopoietic system—sarcoma	0.00281	0.0108	CbGeAlD
Suramin—SIRT1—connective tissue—sarcoma	0.00274	0.0105	CbGeAlD
Suramin—ARSA—connective tissue—sarcoma	0.00271	0.0104	CbGeAlD
Suramin—SIRT5—cardiac atrium—sarcoma	0.00261	0.00998	CbGeAlD
Suramin—F2—mammary gland—sarcoma	0.00247	0.00945	CbGeAlD
Suramin—P2RX4—cardiac atrium—sarcoma	0.00247	0.00944	CbGeAlD
Suramin—ARSA—skin of body—sarcoma	0.00244	0.00935	CbGeAlD
Suramin—PLA2G2A—myometrium—sarcoma	0.00232	0.00888	CbGeAlD
Suramin—RYR1—smooth muscle tissue—sarcoma	0.00232	0.00886	CbGeAlD
Suramin—SIRT5—tendon—sarcoma	0.00227	0.0087	CbGeAlD
Suramin—SIRT1—cardiac atrium—sarcoma	0.00216	0.00827	CbGeAlD
Suramin—SIRT1—uterus—sarcoma	0.00215	0.00823	CbGeAlD
Suramin—P2RX4—tendon—sarcoma	0.00215	0.00823	CbGeAlD
Suramin—PLA2G2A—seminal vesicle—sarcoma	0.0021	0.00802	CbGeAlD
Suramin—P2RX4—bone marrow—sarcoma	0.00208	0.00797	CbGeAlD
Suramin—SIRT1—lymphoid tissue—sarcoma	0.002	0.00767	CbGeAlD
Suramin—PLA2G2A—hematopoietic system—sarcoma	0.00199	0.00763	CbGeAlD
Suramin—RYR1—uterus—sarcoma	0.00199	0.0076	CbGeAlD
Suramin—ARSA—lymphoid tissue—sarcoma	0.00198	0.00757	CbGeAlD
Suramin—PLA2G2A—connective tissue—sarcoma	0.00192	0.00734	CbGeAlD
Suramin—SIRT1—tendon—sarcoma	0.00188	0.00721	CbGeAlD
Suramin—SIRT5—testis—sarcoma	0.00188	0.0072	CbGeAlD
Suramin—SIRT1—bone marrow—sarcoma	0.00182	0.00698	CbGeAlD
Suramin—P2RX4—testis—sarcoma	0.00178	0.00681	CbGeAlD
Suramin—SIRT5—liver—sarcoma	0.00178	0.00681	CbGeAlD
Suramin—PLA2G2A—smooth muscle tissue—sarcoma	0.00175	0.00672	CbGeAlD
Suramin—RYR1—tendon—sarcoma	0.00174	0.00666	CbGeAlD
Suramin—P2RX4—liver—sarcoma	0.00168	0.00644	CbGeAlD
Suramin—PLA2G4A—myometrium—sarcoma	0.00161	0.00618	CbGeAlD
Suramin—SIRT1—testis—sarcoma	0.00156	0.00597	CbGeAlD
Suramin—ARSA—testis—sarcoma	0.00154	0.0059	CbGeAlD
Suramin—PLA2G2A—cardiac atrium—sarcoma	0.00151	0.00579	CbGeAlD
Suramin—F2—hematopoietic system—sarcoma	0.0015	0.00576	CbGeAlD
Suramin—SIRT1—liver—sarcoma	0.00147	0.00564	CbGeAlD
Suramin—PLA2G4A—seminal vesicle—sarcoma	0.00146	0.00558	CbGeAlD
Suramin—ARSA—liver—sarcoma	0.00146	0.00557	CbGeAlD
Suramin—F2—connective tissue—sarcoma	0.00145	0.00554	CbGeAlD
Suramin—RYR1—testis—sarcoma	0.00144	0.00551	CbGeAlD
Suramin—PLA2G2A—lymphoid tissue—sarcoma	0.0014	0.00537	CbGeAlD
Suramin—PLA2G4A—hematopoietic system—sarcoma	0.00139	0.0053	CbGeAlD
Suramin—SIRT5—lymph node—sarcoma	0.00136	0.00522	CbGeAlD
Suramin—RYR1—liver—sarcoma	0.00136	0.00521	CbGeAlD
Suramin—PLA2G4A—connective tissue—sarcoma	0.00133	0.00511	CbGeAlD
Suramin—PLA2G2A—tendon—sarcoma	0.00132	0.00505	CbGeAlD
Suramin—P2RX4—lymph node—sarcoma	0.00129	0.00494	CbGeAlD
Suramin—PLA2G4A—smooth muscle tissue—sarcoma	0.00122	0.00467	CbGeAlD
Suramin—SIRT1—lymph node—sarcoma	0.00113	0.00433	CbGeAlD
Suramin—ARSA—lymph node—sarcoma	0.00112	0.00427	CbGeAlD
Suramin—PLA2G2A—testis—sarcoma	0.00109	0.00418	CbGeAlD
Suramin—F2—lymphoid tissue—sarcoma	0.00106	0.00405	CbGeAlD
Suramin—PLA2G2A—liver—sarcoma	0.00103	0.00395	CbGeAlD
Suramin—F2—bone marrow—sarcoma	0.000964	0.00369	CbGeAlD
Suramin—PLA2G4A—tendon—sarcoma	0.000917	0.00351	CbGeAlD
Suramin—PLA2G4A—bone marrow—sarcoma	0.000888	0.0034	CbGeAlD
Suramin—PLA2G2A—lymph node—sarcoma	0.000791	0.00303	CbGeAlD
Suramin—F2—liver—sarcoma	0.000779	0.00298	CbGeAlD
Suramin—PLA2G4A—testis—sarcoma	0.000759	0.00291	CbGeAlD
Suramin—PLA2G4A—lymph node—sarcoma	0.00055	0.00211	CbGeAlD
Suramin—F2—Peptide ligand-binding receptors—CXCR4—sarcoma	0.00038	0.002	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—JUN—sarcoma	0.000378	0.00199	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000374	0.00197	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CXCR4—sarcoma	0.000371	0.00195	CbGpPWpGaD
Suramin—PLA2G4A—Opioid Signalling—CREB1—sarcoma	0.000368	0.00194	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.000365	0.00192	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—PDGFRB—sarcoma	0.000358	0.00189	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000353	0.00186	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000353	0.00186	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IL2—sarcoma	0.000351	0.00185	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—MDM2—sarcoma	0.00035	0.00184	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CXCR4—sarcoma	0.000349	0.00184	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	0.000345	0.00181	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000344	0.00181	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.000342	0.0018	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—PDGFRB—sarcoma	0.00034	0.00179	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CXCR4—sarcoma	0.000337	0.00177	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—PDGFRA—sarcoma	0.000335	0.00176	CbGpPWpGaD
Suramin—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—sarcoma	0.000335	0.00176	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—MYC—sarcoma	0.000334	0.00176	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—JUN—sarcoma	0.000332	0.00175	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—EGFR—sarcoma	0.000327	0.00172	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—JUN—sarcoma	0.000324	0.0017	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TLE1—sarcoma	0.000323	0.0017	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000317	0.00167	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000314	0.00165	CbGpPWpGaD
Suramin—F2—Hemostasis—TEK—sarcoma	0.000313	0.00165	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TLE1—sarcoma	0.000312	0.00164	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—JUN—sarcoma	0.000312	0.00164	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.00031	0.00163	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—JUN—sarcoma	0.000304	0.0016	CbGpPWpGaD
Suramin—PLA2G4A—PDGF Pathway—HRAS—sarcoma	0.0003	0.00158	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	0.000293	0.00154	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000293	0.00154	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—SRC—sarcoma	0.000291	0.00153	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TEK—sarcoma	0.000287	0.00151	CbGpPWpGaD
Suramin—F2—Hemostasis—ANGPT2—sarcoma	0.000287	0.00151	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—SRC—sarcoma	0.00028	0.00147	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TP53—sarcoma	0.000275	0.00145	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFC—sarcoma	0.000273	0.00144	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—VEGFA—sarcoma	0.000266	0.0014	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFC—sarcoma	0.000264	0.00139	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ANGPT2—sarcoma	0.000262	0.00138	CbGpPWpGaD
Suramin—ARSA—Metabolism—ENO2—sarcoma	0.00026	0.00137	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.00026	0.00137	CbGpPWpGaD
Suramin—ARSA—Metabolism—HBA1—sarcoma	0.000258	0.00136	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000255	0.00134	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000251	0.00132	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—TP53—sarcoma	0.00025	0.00131	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—EGFR—sarcoma	0.000245	0.00129	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFC—sarcoma	0.00023	0.00121	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TP53—sarcoma	0.000225	0.00119	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—SRC—sarcoma	0.000221	0.00116	CbGpPWpGaD
Suramin—ARSA—Metabolism—PLCG1—sarcoma	0.000221	0.00116	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—FLT1—sarcoma	0.000218	0.00115	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PLCG1—sarcoma	0.000214	0.00113	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—NRAS—sarcoma	0.000213	0.00112	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FLT1—sarcoma	0.000211	0.00111	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFC—sarcoma	0.00021	0.00111	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—sarcoma	0.00021	0.0011	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PLCG1—sarcoma	0.000207	0.00109	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CXCR4—sarcoma	0.000206	0.00108	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—MMP2—sarcoma	0.000205	0.00108	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—HRAS—sarcoma	0.000204	0.00108	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ATF1—sarcoma	0.000204	0.00107	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—TP53—sarcoma	0.000201	0.00106	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CXCR4—sarcoma	0.000199	0.00105	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ATF1—sarcoma	0.000197	0.00104	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CXCR4—sarcoma	0.000194	0.00102	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—JUN—sarcoma	0.000187	0.000985	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CREB1—sarcoma	0.000187	0.000983	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000185	0.000976	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	0.000184	0.000971	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—KRAS—sarcoma	0.000183	0.000964	CbGpPWpGaD
Suramin—F2—Hemostasis—PLCG1—sarcoma	0.000181	0.000951	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CREB1—sarcoma	0.00018	0.000949	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—SRC—sarcoma	0.000168	0.000884	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ENO2—sarcoma	0.000168	0.000882	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—HBA1—sarcoma	0.000167	0.000877	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PLCG1—sarcoma	0.000165	0.00087	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—NRAS—sarcoma	0.000162	0.00085	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IGF1R—sarcoma	0.00016	0.000841	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—CTNNB1—sarcoma	0.000157	0.000828	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—HRAS—sarcoma	0.000156	0.00082	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IGF1R—sarcoma	0.000154	0.000812	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—NRAS—sarcoma	0.000153	0.000808	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000153	0.000808	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—FOXO1—sarcoma	0.000152	0.000801	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—IL2—sarcoma	0.000152	0.0008	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PDGFRB—sarcoma	0.000152	0.000799	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—MYC—sarcoma	0.00015	0.000792	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PDGFRA—sarcoma	0.000149	0.000787	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FOXO1—sarcoma	0.000147	0.000773	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—IL2—sarcoma	0.000147	0.000773	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PDGFRB—sarcoma	0.000147	0.000772	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PDGFRA—sarcoma	0.000144	0.00076	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PLCG1—sarcoma	0.000142	0.000749	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—EGFR—sarcoma	0.00014	0.000736	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—KRAS—sarcoma	0.000139	0.000732	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL2—sarcoma	0.000138	0.000727	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000134	0.000703	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—IL2—sarcoma	0.000133	0.000702	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000133	0.000702	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL2—sarcoma	0.000133	0.000702	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000132	0.000697	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—KRAS—sarcoma	0.000132	0.000695	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KDR—sarcoma	0.000126	0.000662	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—sarcoma	0.000122	0.000642	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KDR—sarcoma	0.000122	0.00064	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.00012	0.00063	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—HRAS—sarcoma	0.000118	0.000622	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000117	0.000613	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—SRC—sarcoma	0.000116	0.000613	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KIT—sarcoma	0.000116	0.00061	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—NRAS—sarcoma	0.000116	0.00061	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	0.000114	0.000602	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—VEGFA—sarcoma	0.000113	0.000597	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KIT—sarcoma	0.000112	0.000589	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—NRAS—sarcoma	0.000112	0.000589	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CREB1—sarcoma	0.00011	0.000581	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCR4—sarcoma	0.00011	0.000578	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000107	0.000564	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CREB1—sarcoma	0.000107	0.000561	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—SRC—sarcoma	0.000106	0.00056	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—EGFR—sarcoma	0.000106	0.000556	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000105	0.000552	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.000104	0.000549	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—sarcoma	0.000104	0.000546	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—EGFR—sarcoma	0.000102	0.000537	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—KRAS—sarcoma	9.98e-05	0.000525	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCR4—sarcoma	9.96e-05	0.000524	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	9.91e-05	0.000521	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	9.85e-05	0.000519	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—KRAS—sarcoma	9.64e-05	0.000507	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TLE1—sarcoma	9.24e-05	0.000486	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MDM2—sarcoma	9.13e-05	0.00048	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCR4—sarcoma	9.11e-05	0.00048	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MDM2—sarcoma	8.82e-05	0.000464	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	8.8e-05	0.000463	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HRAS—sarcoma	8.48e-05	0.000446	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TLE1—sarcoma	8.45e-05	0.000445	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	8.37e-05	0.000441	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HRAS—sarcoma	8.19e-05	0.000431	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL2—sarcoma	8.16e-05	0.000429	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCND1—sarcoma	7.95e-05	0.000419	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—JUN—sarcoma	7.93e-05	0.000418	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ENO2—sarcoma	7.9e-05	0.000416	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL2—sarcoma	7.88e-05	0.000415	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CTNNB1—sarcoma	7.87e-05	0.000414	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—HBA1—sarcoma	7.85e-05	0.000413	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFC—sarcoma	7.8e-05	0.00041	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCND1—sarcoma	7.68e-05	0.000404	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—JUN—sarcoma	7.66e-05	0.000403	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CTNNB1—sarcoma	7.61e-05	0.0004	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MYC—sarcoma	7.57e-05	0.000399	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFC—sarcoma	7.13e-05	0.000375	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SRC—sarcoma	7.12e-05	0.000375	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFA—sarcoma	6.93e-05	0.000365	CbGpPWpGaD
Suramin—F2—Hemostasis—IL2—sarcoma	6.88e-05	0.000362	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SRC—sarcoma	6.87e-05	0.000362	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NRAS—sarcoma	6.85e-05	0.00036	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MMP2—sarcoma	6.81e-05	0.000358	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PLCG1—sarcoma	6.7e-05	0.000353	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFA—sarcoma	6.7e-05	0.000352	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NRAS—sarcoma	6.61e-05	0.000348	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MYC—sarcoma	6.38e-05	0.000336	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IL2—sarcoma	6.29e-05	0.000331	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EGFR—sarcoma	6.24e-05	0.000328	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FLT1—sarcoma	6.23e-05	0.000328	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MYC—sarcoma	6.16e-05	0.000324	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PLCG1—sarcoma	6.13e-05	0.000322	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EGFR—sarcoma	6.03e-05	0.000317	CbGpPWpGaD
Suramin—F2—Hemostasis—SRC—sarcoma	6e-05	0.000316	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KRAS—sarcoma	5.89e-05	0.00031	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCR4—sarcoma	5.89e-05	0.00031	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFA—sarcoma	5.84e-05	0.000308	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ATF1—sarcoma	5.82e-05	0.000306	CbGpPWpGaD
Suramin—F2—Hemostasis—NRAS—sarcoma	5.77e-05	0.000304	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FLT1—sarcoma	5.7e-05	0.0003	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KRAS—sarcoma	5.69e-05	0.0003	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PLCG1—sarcoma	5.6e-05	0.000295	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SRC—sarcoma	5.49e-05	0.000289	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCR4—sarcoma	5.38e-05	0.000283	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFA—sarcoma	5.34e-05	0.000281	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CREB1—sarcoma	5.34e-05	0.000281	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ATF1—sarcoma	5.32e-05	0.00028	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—NRAS—sarcoma	5.28e-05	0.000278	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—sarcoma	5.24e-05	0.000276	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CTNNB1—sarcoma	5.22e-05	0.000275	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—sarcoma	5.06e-05	0.000266	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HRAS—sarcoma	5.01e-05	0.000264	CbGpPWpGaD
Suramin—F2—Hemostasis—KRAS—sarcoma	4.97e-05	0.000261	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CREB1—sarcoma	4.88e-05	0.000257	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HRAS—sarcoma	4.84e-05	0.000255	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF1R—sarcoma	4.57e-05	0.00024	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—KRAS—sarcoma	4.54e-05	0.000239	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—sarcoma	4.42e-05	0.000232	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FOXO1—sarcoma	4.35e-05	0.000229	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—IL2—sarcoma	4.35e-05	0.000229	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PDGFRB—sarcoma	4.34e-05	0.000228	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PDGFRA—sarcoma	4.27e-05	0.000225	CbGpPWpGaD
Suramin—F2—Hemostasis—HRAS—sarcoma	4.22e-05	0.000222	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF1R—sarcoma	4.18e-05	0.00022	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—sarcoma	4.04e-05	0.000213	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FOXO1—sarcoma	3.98e-05	0.000209	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PDGFRB—sarcoma	3.97e-05	0.000209	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL2—sarcoma	3.95e-05	0.000208	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PDGFRA—sarcoma	3.91e-05	0.000206	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—HRAS—sarcoma	3.86e-05	0.000203	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL2—sarcoma	3.61e-05	0.00019	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KDR—sarcoma	3.6e-05	0.000189	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KIT—sarcoma	3.31e-05	0.000174	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—NRAS—sarcoma	3.31e-05	0.000174	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KDR—sarcoma	3.29e-05	0.000173	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CREB1—sarcoma	3.15e-05	0.000166	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KIT—sarcoma	3.03e-05	0.000159	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—NRAS—sarcoma	3.03e-05	0.000159	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EGFR—sarcoma	3.02e-05	0.000159	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CREB1—sarcoma	2.88e-05	0.000152	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—KRAS—sarcoma	2.85e-05	0.00015	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EGFR—sarcoma	2.76e-05	0.000145	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MDM2—sarcoma	2.61e-05	0.000137	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—KRAS—sarcoma	2.61e-05	0.000137	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HRAS—sarcoma	2.42e-05	0.000128	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MDM2—sarcoma	2.39e-05	0.000126	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL2—sarcoma	2.33e-05	0.000123	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCND1—sarcoma	2.27e-05	0.00012	CbGpPWpGaD
Suramin—F2—Signaling Pathways—JUN—sarcoma	2.27e-05	0.000119	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CTNNB1—sarcoma	2.25e-05	0.000118	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HRAS—sarcoma	2.22e-05	0.000117	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL2—sarcoma	2.13e-05	0.000112	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCND1—sarcoma	2.08e-05	0.000109	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—JUN—sarcoma	2.07e-05	0.000109	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CTNNB1—sarcoma	2.06e-05	0.000108	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SRC—sarcoma	2.03e-05	0.000107	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFA—sarcoma	1.98e-05	0.000104	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NRAS—sarcoma	1.96e-05	0.000103	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SRC—sarcoma	1.86e-05	9.79e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MYC—sarcoma	1.82e-05	9.59e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFA—sarcoma	1.81e-05	9.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NRAS—sarcoma	1.79e-05	9.42e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EGFR—sarcoma	1.78e-05	9.38e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KRAS—sarcoma	1.68e-05	8.86e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MYC—sarcoma	1.67e-05	8.77e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EGFR—sarcoma	1.63e-05	8.58e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KRAS—sarcoma	1.54e-05	8.11e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—sarcoma	1.5e-05	7.88e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HRAS—sarcoma	1.43e-05	7.53e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—sarcoma	1.37e-05	7.21e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HRAS—sarcoma	1.31e-05	6.89e-05	CbGpPWpGaD
